Active Biotech is developing pharmaceutical products within medical areas where the immune defense is of significant importance like inflammatory disease and various forms of cancer.

Active Biotech’s share is listed on the NASDAQ OMX Nordic Exchange (Stockholm) since 1986 and the company has approximately 14,500 shareholders.

Short Name

Financial Reports

Latest Presentation

Infocus interview with CEO Helen Tuvesson at Redeye Growth Day 2023, June 1

Events and Financial Calendar

Date: November 9, 2023
Date: February 8, 2024

Helén Tuvesson

IR Contact

Phone: +46 46 19 21 56


Hans Kolam

IR Contact

Phone: +46 46 19 20 44